{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:06:14Z","timestamp":1760918774476,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bmc.2021.116465","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T02:58:04Z","timestamp":1634093884000},"page":"116465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis of PF-6870961, a major hydroxy metabolite of the novel ghrelin receptor inverse agonist PF-5190457"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8849-9736","authenticated-orcid":false,"given":"Agnieszka","family":"Sulima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-7615","authenticated-orcid":false,"given":"Fatemeh","family":"Akhlaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-8754","authenticated-orcid":false,"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116465_b0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.irn.2017.08.002","article-title":"The Role of the Ghrelin System in Drug Addiction","volume":"136","author":"Zallar","year":"2017","journal-title":"Int Rev Neurobiol."},{"key":"10.1016\/j.bmc.2021.116465_b0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.physbeh.2019.02.008","article-title":"Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder","volume":"204","author":"Farokhnia","year":"2019","journal-title":"Physiol Behav."},{"key":"10.1016\/j.bmc.2021.116465_b0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/ml400473x","article-title":"Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate","volume":"5","author":"Bhattacharya","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bmc.2021.116465_b0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41380-018-0064-y","article-title":"The Novel Ghrelin Receptor Inverse Agonist PF-5190457 Administered with Alcohol: Preclinical Safety Experiments and a Phase 1b Human Laboratory Study","volume":"25","author":"Lee","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bmc.2021.116465_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107788","article-title":"Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers","volume":"170","author":"Lee","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmc.2021.116465_b0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bcp.13127","article-title":"Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects","volume":"83","author":"Denney","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bmc.2021.116465_b0035","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1124\/dmd.119.087015","article-title":"Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach","volume":"47","author":"Adusumalli","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bmc.2021.116465_b0040","article-title":"Development and validation of an assay for a novel ghrelin receptor inverse agonist PF-5190457 and its major hydroxy metabolite (PF-6870961) by LC-MS\/MS in human plasma","volume":"1130\u20131131","author":"Adusumalli","year":"2019","journal-title":"J. Chromatogr B"},{"key":"10.1016\/j.bmc.2021.116465_b0045","unstructured":"Kubota, Y.; Kanno, H.; Sato, T.; Arahira, M. Herbicidal Composition Containing 2-Benzyloxypyrimidine Derivatives, Processes for Producing the Derivatives and 2-Benzyloxypyrimidine Derivatives. US 005599770 A."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:15:26Z","timestamp":1760836526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621004739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":9,"alternative-id":["S0968089621004739"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116465","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of PF-6870961, a major hydroxy metabolite of the novel ghrelin receptor inverse agonist PF-5190457","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116465"}}